SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-066731
Filing Date
2017-11-08
Accepted
2017-11-07 19:17:11
Documents
52
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20642_110q.htm 10-Q 1028441
2 EX-10.1 a17-20642_1ex10d1.htm EX-10.1 29564
3 EX-10.2 a17-20642_1ex10d2.htm EX-10.2 76755
4 EX-10.3 a17-20642_1ex10d3.htm EX-10.3 77872
5 EX-31.1 a17-20642_1ex31d1.htm EX-31.1 12995
6 EX-31.2 a17-20642_1ex31d2.htm EX-31.2 12948
7 EX-32 a17-20642_1ex32.htm EX-32 10594
  Complete submission text file 0001104659-17-066731.txt   3672407

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT tbph-20170930.xml EX-101.INS 561860
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tbph-20170930.xsd EX-101.SCH 27736
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tbph-20170930_cal.xml EX-101.CAL 46219
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tbph-20170930_def.xml EX-101.DEF 105681
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tbph-20170930_lab.xml EX-101.LAB 277526
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tbph-20170930_pre.xml EX-101.PRE 207073
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36033 | Film No.: 171184764
SIC: 2834 Pharmaceutical Preparations